Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Shares Issued (2019 - 2025)

Benitec Biopharma's Shares Issued history spans 6 years, with the latest figure at $30.5 million for Q1 2025.

  • For Q1 2025, Shares Issued rose 78200.0% year-over-year to $30.5 million; the TTM value through Mar 2025 reached $70.5 million, up 128.15%, while the annual FY2024 figure was $70.9 million, 296.35% up from the prior year.
  • Shares Issued for Q1 2025 was $30.5 million at Benitec Biopharma, down from $40.0 million in the prior quarter.
  • Across five years, Shares Issued topped out at $40.0 million in Q2 2024 and bottomed at -$39000.0 in Q1 2024.
  • The 5-year median for Shares Issued is $16.1 million (2021), against an average of $16.7 million.
  • The largest annual shift saw Shares Issued skyrocketed 72.69% in 2023 before it skyrocketed 78200.0% in 2025.
  • A 5-year view of Shares Issued shows it stood at $14.3 million in 2021, then grew by 25.48% to $17.9 million in 2022, then crashed by 99.78% to $39000.0 in 2023, then soared by 102464.1% to $40.0 million in 2024, then dropped by 23.85% to $30.5 million in 2025.
  • Per Business Quant, the three most recent readings for BNTC's Shares Issued are $30.5 million (Q1 2025), $40.0 million (Q2 2024), and -$39000.0 (Q1 2024).